Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical applies for Orphan Drug status for Renaparin at FDA

Nov 3 (Reuters) - Corline Biomedical AB  CLBIO.ST : 
    * Applies for Orphan Drug status for Renaparin at U.S. Food and Drug Administration (FDA) 
 
Source text for Eikon:  ID:nHUG2Q9V7J  
     
Further company coverage:  CLBIO.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Corline Biomedical AB

See all news